Chronic graft versus host disease Trials in Seattle, United States
Conditions / Chronic graft versus host disease / Seattle, United States
Chronic graft versus host disease has been the subject of sustained clinical investigation across multiple research sites.
23 total trials for this combination
Showing top 10 of 23 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07124078 | A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256) | RECRUITING | — |
| NCT03584516 | GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease | TERMINATED | PHASE2/PHASE3 |
| NCT03790332 | Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD) | COMPLETED | PHASE1/PHASE2 |
| NCT01804686 | A Long-term Extension Study of PCI-32765 (Ibrutinib) | RECRUITING | PHASE3 |
| NCT02959944 | Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Participants With New Onset Chronic Graft Versus Host Disease (cGVHD) | COMPLETED | PHASE3 |
| NCT00637689 | Improving Outcomes Assessment in Chronic GVHD | ACTIVE_NOT_RECRUITING | — |
| NCT06388564 | A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease | RECRUITING | PHASE2 |
| NCT03640481 | Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy | TERMINATED | PHASE2 |
| NCT04710576 | A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD) | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT06143891 | A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease. | ACTIVE_NOT_RECRUITING | PHASE3 |